Login

Interview with Genasys CEO Richard S. Danforth on company developments and industry insights. 00:10:00

Share On Facebook Share On Twitter

Richard S. Danforth is the CEO of Genasys.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
GoGold Resources: Management Track Record and Tailings Reprocessing Success in Mexico
00:10:00
Becoming a Fortune 500 CEO: Brent Saunders on Strategy, Success, and Scaling in Big Pharma | Brent Saunder , CEO, Bausch + Lomb corp.
00:10:00
Idinvest Partners' Commitment to European Mid-Market Private Equity | Christophe Bavière, CEO, Idinvest Partners.
00:10:00
BlackRock Mining - Mahinga Project Overview
00:10:00
Unlocking Potential: Noront Resources Ltd. | Alan Coutts - CEO of Noront Resources.
00:10:00
"Fredrik Brag, CEO of Median, discusses the exceptional performance of iBiopsy® Lung Cancer Screening CADx and Median's confirmation as a preferred vendor by a Top 3 pharma company."|Fredrik Brag, CEO of Median,
00:00:00
Anthropologist and psychiatrist / Anne E. Becker, MD, PhD, ScM Dean for Clinical and Academic Affairs, HMS
00:10:00
Thor Explorations: Unveiling West Africa's Potential at One-to-One Mining Conference in London
00:10:00
MolyWorks Improves Air-Worthy Aerospace Part Production Capabilities | Jeffrey A Graves, CEO, 3D Systems CorpDDD:NYQ
00:10:00
A Leading Global Asset Manager Specializing in the Public & Private Credit Markets|Bruce Richards,CEO, Chairman, & Founder,Marathon
00:10:00
The Cramdown Podcast: Meet O'Melveny's New Dallas Bankruptcy Partners | Lou Strubeck Jr. - Partner, O'Melveny & Myers LLP
00:10:00
Kevin Mahn, president and CIO of Hennion & Walsh Asset Management, shares insights in a widely viewed video on Reppond Investments, Inc.

© 2017 - Neuhu+